Sarah Barry

Dr. Sarah Barry is an Associate Professor in the Department of Chemistry at King's College London, specializing in Chemical Biology. She leads the Barry Group, focusing on microbial natural product biosynthesis, antimicrobial resistance, and enzymology-driven biocatalysis. Her work integrates organic chemistry, molecular microbiology, and spectroscopic techniques to develop sustainable synthesis methods and combat AMR.

• Education:
  • BSc (Hons) in Chemistry from University College Dublin (UCD), supervised by Prof. Patrick Guiry.
  • PhD in Chemistry from UCD under Dr. Peter Rutledge, with final year at University of Sydney.
  • Postdoctoral research at University of Warwick with Prof. Greg Challis, studying thaxtomin biosynthesis.
• Research Interests:
  • Natural product discovery and biosynthetic pathway analysis.
  • Development of biocatalysts from enzymatic systems.
  • Engineering peptides for novel antibiotics.
  • Siderophore biology and antimicrobial treatments.
• Awards:
  • Herbert Tabor Young Investigator Award (2011).
  • Hugh Ryan Memorial Medal (2004).
• Grants & Projects:
  • Funding from EPSRC, MRC, BBSRC, and Royal Society of Chemistry.
  • Current projects include metallo-peptide antibiotics and chemoenzymatic functionalization.
• Lab & Teams:
  • Barry Group at King's College London, collaborating with UCL and international institutions.
  • Focus on interdisciplinary approaches to tackle AMR and sustainable chemistry.